© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
UVA Health
Latest from UVA Health
Insights on Vortioxetine for Treatment-Emergent Sexual Dysfunction
December 08, 2018
Article
Investigator Anita Clayton, MD, shares insights into the new vortioxetine data and its implications for patients with depression and treatment-emergent sexual dysfunction.
Robert Battle, MD: Treating Hypertrophic Cardiomyopathy as a Sports Cardiologist
October 25, 2018
Article
Along with sports cardiology and pediatric cardiology, Robert Battle specializes in treating patients with hypertrophic cardiomyopathy, the most common genetic cardiovascular disorder.
Label Update Shows Vortioxetine as Effective for Treatment-Emergent Sexual Dysfunction
October 22, 2018
Article
A supplemental new drug application (sNDA) for vortioxetine (TRINTELLIX), a prescription medication for the treatment of adults with major depressive disorder (MDD), has been accepted by the FDA.
Q&A: J. Michael Mangrum, MD, on UVA's Work with CardioInsight
September 01, 2018
Article
The heart rhythm specialist with the UVA Advanced Imaging group discussed his team's early successes with Medtronic's heart ablation vest.